Adherium Limited (ADR.AX)
AUD 0.01
(0.0%)
AUD 0.01
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 1.58 Million AUD | 27.71% |
| 2023 | 1.23 Million AUD | 15.69% |
| 2022 | 1.07 Million AUD | 11.33% |
| 2021 | 962 Thousand AUD | -14.11% |
| 2020 | 1.12 Million AUD | 168.59% |
| 2019 | 417 Thousand AUD | -18.07% |
| 2018 | 509 Thousand AUD | -29.89% |
| 2017 | 726 Thousand AUD | 73.68% |
| 2016 | 418 Thousand AUD | -56.86% |
| 2015 | 969 Thousand AUD | 441.52% |
| 2014 | 178.94 Thousand AUD | 427.51% |
| 2013 | 33.92 Thousand AUD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 FY | 1.58 Million AUD | 27.71% |
| 2024 Q2 | 1.47 Million AUD | 0.0% |
| 2024 Q4 | 1.58 Million AUD | 0.0% |
| 2023 Q4 | 1.23 Million AUD | 0.0% |
| 2023 Q2 | 1.11 Million AUD | 0.0% |
| 2023 FY | 1.23 Million AUD | 15.69% |
| 2022 Q2 | 1 Million AUD | 0.0% |
| 2022 Q4 | 1.07 Million AUD | 0.0% |
| 2022 FY | 1.07 Million AUD | 11.33% |
| 2021 Q2 | 1.09 Million AUD | 0.0% |
| 2021 Q4 | 962 Thousand AUD | 0.0% |
| 2021 FY | 962 Thousand AUD | -14.11% |
| 2020 Q4 | 1.12 Million AUD | 0.0% |
| 2020 FY | 1.12 Million AUD | 168.59% |
| 2020 Q2 | 566 Thousand AUD | 0.0% |
| 2019 Q2 | 406 Thousand AUD | 0.0% |
| 2019 Q4 | 417 Thousand AUD | 0.0% |
| 2019 FY | 417 Thousand AUD | -18.07% |
| 2018 FY | 509 Thousand AUD | -29.89% |
| 2018 Q4 | 509 Thousand AUD | 0.0% |
| 2018 Q2 | 570 Thousand AUD | 0.0% |
| 2017 Q4 | 726 Thousand AUD | 0.0% |
| 2017 FY | 726 Thousand AUD | 73.68% |
| 2017 Q2 | 730 Thousand AUD | 0.0% |
| 2016 FY | 418 Thousand AUD | -56.86% |
| 2015 FY | 969 Thousand AUD | 441.52% |
| 2014 FY | 178.94 Thousand AUD | 427.51% |
| 2013 FY | 33.92 Thousand AUD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| 4DMedical Limited | 992.24 Thousand AUD | -59.466% |
| Aroa Biosurgery Limited | 7.43 Million AUD | 78.704% |
| Atomo Diagnostics Limited | 1.83 Million AUD | 13.947% |
| Anteris Technologies Ltd | 646.71 Thousand AUD | -144.668% |
| Control Bionics Limited | 404.15 Thousand AUD | -291.513% |
| CardieX Limited | 2.55 Million AUD | 38.034% |
| Compumedics Limited | 13.21 Million AUD | 88.023% |
| Cochlear Limited | 391.6 Million AUD | 99.596% |
| CleanSpace Holdings Limited | 2.86 Million AUD | 44.781% |
| Cyclopharm Limited | 10.12 Million AUD | 84.368% |
| EMVision Medical Devices Ltd | - AUD | -Infinity% |
| Nova Eye Medical Limited | 4.28 Million AUD | 63.056% |
| HeraMED Limited | 361.61 Thousand AUD | -337.568% |
| Imricor Medical Systems, Inc. | 2.46 Million AUD | 35.785% |
| ImpediMed Limited | 759 Thousand AUD | -108.471% |
| InhaleRx Limited | - AUD | -Infinity% |
| LBT Innovations Limited | 1.61 Million AUD | 2.207% |
| Micro-X Limited | 5.37 Million AUD | 70.584% |
| Neurotech International Limited | - AUD | -Infinity% |
| OncoSil Medical Limited | 391.67 Thousand AUD | -303.987% |
| PolyNovo Limited | 8.97 Million AUD | 82.364% |
| Respiri Limited | 2.75 Million AUD | 42.495% |
| SomnoMed Limited | 6.28 Million AUD | 74.826% |
| Universal Biosensors, Inc. | 4.37 Million AUD | 63.857% |
| Uscom Limited | 623.62 Thousand AUD | -153.725% |
| Visioneering Technologies, Inc. | 3.16 Million AUD | 50.038% |